ArticlePublic health genomics2012
The impact of genomics on public health practice: the case for change.
Article in Public health genomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Assessment of physician preparedness for implementation of pathology-supported genetic testing: solution-driven post-COVID-19 survey.Frontiers in genetics · 2025Article
- Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, challenges, and recommendations.Journal of medical virology · 2023Review
- Comparing the attitudes of physicians and non-physicians toward communicating a patient's BRCA1 mutation to a first-degree relative against a patient's wishes.Journal of community genetics · 2022Article
- Web search behaviors and infodemic attitudes regarding COVID-19 in Turkey: A framework study for improving response and informing policy on the COVID-19 infodemic.Frontiers in public health · 2022Article
- Genomics knowledge and attitudes among European public health professionals: Results of a cross-sectional survey.PloS one · 2020Article
- Article
- Personalized medicine in Europe: not yet personal enough?BMC health services research · 2017Review
- Public Views on Genetics and Genetic Testing: A Survey of the General Public in Belgium.Genetic testing and molecular biomarkers · 2017Article
- The hallmarks of premalignant conditions: a molecular basis for cancer prevention.Seminars in oncology · 2016Review
- Increasing participation in genomic research and biobanking through community-based capacity building.Journal of genetic counseling · 2015Article
- Beyond public health genomics: proposals from an international working group.European journal of public health · 2014Article
- Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy.BMC health services research · 2014Article
- Life insurance: genomic stratification and risk classification.European journal of human genetics : EJHG · 2014Article
- Dysmorphology at a distance: results of a web-based diagnostic service.European journal of human genetics : EJHG · 2014Article
- Informed decision-making among students analyzing their personal genomes on a whole genome sequencing course: a longitudinal cohort study.Genome medicine · 2013Article
- Moving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Public health practice will not be able in the 21st century to ignore the impact of genomics, cell and molecular biology. It will need to take into consideration issues that include, among others: the complementary nature of social and biological models of disease, genetic exceptionalism, the readiness of public and patient to respond to genomic information, the relationship between individuals and populations, and concepts of population stratification. Health systems will need to adapt their practice and organisation to include new sequencing technologies, bioinformatic expertise and proper evaluation of genetic and molecular tests. Links with the commercial sector will increase in importance. The impact on developing countries cannot be ignored and will require special attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.